Difference between revisions of "Committees"
Jump to navigation
Jump to search
Line 1: | Line 1: | ||
+ | [[Media:2-QIBA Committee Structure 1-12-15.pdf|QIBA Committee Structure Description]] | ||
+ | |||
+ | |||
+ | * '''[[Steering Committee]]''' | ||
+ | |||
+ | :* '''[[CT Coordinating Committee]]''' | ||
+ | ::* [[CT Volumetry tech ctte|CT Volumetry Biomarker Committee]] | ||
+ | :::* Volumetry Algorithm Challenge TF | ||
+ | :::* Small Lung Nodule TF | ||
+ | :::* QIBA/fNIH FDA Biomarker Qualification Partnership | ||
+ | ::* [[COPD-Asthma tech ctte|COPD-Asthma Biomarker Committee]] | ||
+ | :::* Airway Measurement TF | ||
+ | |||
+ | :* '''[[MR Coordinating Committee]]''' | ||
+ | ::* [[Perfusion, Diffusion and Flow-MRI tech ctte|PDF-MRI Biomarker Committee]] | ||
+ | :::* DW-MR TF | ||
+ | :::* DCE-MRI TF | ||
+ | :::* MRE TF | ||
+ | :::* Other TFs (DTI, DSC, Fat Fraction) | ||
+ | ::* [[FMRI tech ctte|fMRI Biomarker Committee]] | ||
+ | |||
+ | :* '''[[NM Coordinating Committee]]''' | ||
+ | ::* [[FDG-PET Biomarker Committee]] | ||
+ | :::* Profile Compliance TF | ||
+ | :::* FDG-PET UPICT TF | ||
+ | :::* QIBA/fNIH FDA Biomarker Qualification Partnership | ||
+ | ::* [[PET-Amyloid Biomarker Committee]] | ||
+ | ::* SPECT TF | ||
+ | |||
+ | :* '''[[US Coordinating Committee]]''' | ||
+ | ::* [[Ultrasound SWS tech ctte|Ultrasound SWS Biomarker Committee]] | ||
+ | :::* System Dependencies/Phantom Testing TF | ||
+ | :::* Clinical Applications TF | ||
+ | |||
+ | :* '''[[Process Coordinating Committee]]''' | ||
+ | |||
+ | |||
{| style="width:95%" border="1" cellpadding="3" | {| style="width:95%" border="1" cellpadding="3" | ||
! Committee | ! Committee |
Revision as of 17:48, 21 May 2015
QIBA Committee Structure Description
-
-
- Volumetry Algorithm Challenge TF
- Small Lung Nodule TF
- QIBA/fNIH FDA Biomarker Qualification Partnership
- Airway Measurement TF
-
-
-
- DW-MR TF
- DCE-MRI TF
- MRE TF
- Other TFs (DTI, DSC, Fat Fraction)
-
-
-
- Profile Compliance TF
- FDG-PET UPICT TF
- QIBA/fNIH FDA Biomarker Qualification Partnership
- PET-Amyloid Biomarker Committee
- SPECT TF
-
-
-
- System Dependencies/Phantom Testing TF
- Clinical Applications TF
-
Committee | Co-chairs | ||
---|---|---|---|
QIBA Steering Committee | Daniel C. Sullivan, MD (QIBA Chair); Edward F. Jackson, PhD (QIBA Vice-Chair) | ||
PDF-MRI Technical Committee | Marko Ivancevic, PhD; Edward F. Jackson, PhD; Gudrun Zahlmann, PhD | ||
fMRI Technical Committee | Edgar (Ted) DeYoe, PhD; Cathy Elsinger, PhD; Jeffrey Petrella, MD | ||
FDG-PET Technical Committee | Paul E. Kinahan, PhD; Ling X. Shao, PhD; Richard L. Wahl, MD | ||
CT Volumetry Technical Committee | Samuel G. Armato III, PhD; Gregory V. Goldmacher, MD, PhD; Lawrence H. Schwartz, MD | ||
COPD-Asthma Technical Committee | Philip F. Judy, PhD | ||
Ultrasound SWS Technical Committee | Brian Garra, MD; Tim J. Hall, PhD; Andrzej (Andy) Milkowski, MS |